Inclusion Criteria:

- Men 18 years or older (19 years in BC) with a histologic diagnosis of clinically
localized prostate cancer prior to radical prostatectomy as defined by:

1. Clinical state T1-T2

2. PSA <20

3. Gleason score ≤ 7

- ECOG performance status of 0-1.

- Life expectancy greater than 10 years.

- Able to understand and give informed consent.

- Laboratory values must be as follows:

1. White blood cell count: ≥ 3,000/mm^3

2. Absolute granulocyte count: ≥ 1,500/mm^3

3. Platelets: ≥ 100,000/mm^3

4. Hemoglobin: ≥ 12g/dL

5. Serum creatinine: ≤ 1.5 x ULN

6. AST: ≤ 2 x ULN

7. ALT: ≤ 2 x ULN

8. Serum calcium: ≤ ULN

9. Total bilirubin: ≤ 1.5 x ULN

Exclusion Criteria:

- Patients who are receiving any other investigational therapy.

- Patients who have received or are receiving any other treatment for their prostate
cancer.

- Patients with an active serious infection or other serious underlying medical
condition that would otherwise impair their ability to receive protocol treatment.

- Dementia or significantly altered mental status that would prohibit the understanding
and/or giving of informed consent.

- Histologic evidence of small cell carcinoma of the prostate.

- Patients who are currently receiving active therapy for other neoplastic disorders
will not be eligible for study.

- Patients who are receiving any androgens, estrogens or progestational agents.

- Patients with a known hypersensitivity to pomegranates or composites of the
capsules/placebo: hydroxypropyl methylcellulose, silicon dioxide or aerosol.

- Patients who are taking any drugs or natural health products which might impact
biochemical tests (some examples include: spironolactone, aprepitant, bexarotene,
clarithromycin, itraconazole, ketoconazole, St. John's wort). A washout period of 30
days prior to commencing the study would be necessary for these compounds if
required.

- Patients who have chronic active hepatitis.

- Medical conditions, which, in the opinion of the investigators would jeopardize
either the patient or the integrity of the data obtained.